A comparison of antibody responses to: Veterinary vaccine antigens potentiated by different adjuvants

Vaccine

Volumn 15, Issue 17-18, 1997, Pages 1902-1907

  Usinger, William R ^a  

^a Immusine Inc   (United States)

Author keywords

Adjuvant; FeLV, feline leukemia virus; FIV, feline immunodeficiency virus; GBA, gliding bacterial adjuvant; IFA, incomplete Freund's adjuvant; Vaccine; Vehicle

Indexed keywords

ACEMANNAN; ALUMINUM HYDROXIDE; FELINE LEUKEMIA VIRUS VACCINE; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; VIRUS VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIROFILARIA IMMITIS; DRUG POTENTIATION; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, HELMINTH; ANTIBODIES, VIRAL; ANTIGENS, BACTERIAL; ANTIGENS, HELMINTH; BACTERIA; CATS; DIROFILARIA IMMITIS; DRUG SYNERGISM; GELS; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOENZYME TECHNIQUES; LEUKEMIA VIRUS, FELINE; MICE; MICE, INBRED BALB C; PARTICLE SIZE; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0030834536     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00136-9     Document Type: Article

References (9)

1. Glenny, A. T., Pope, C. G., Waddington, H. and Wallace, U. The antigenic value of toxoid precipitated by potassium alum. Journal of Pathology and Bacteriology 1926, 29, 38-45.
2. Gupta, R. K., Rost, B. E., Relyveld, E. and Siber, G. R. Adjuvant properties of aluminum and calcium compounds. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M. F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 229-242
3. Vogel, F. R. and Powell, M. F. A compendium of vaccine adjuvants and excipients. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M. F. and Newman, M. J.). Plenum Press, New York, 1995, pp. 141-227
4. Usinger, W. R. and Mishell, R. I. Chemical characterization and immunoenhancing activities of purified Cytophaga exopolymer. In: Vaccine Adjuvants and Modulators of Non-specific Resistance (Ed Majde, J. A.). Alan R. Liss, New York, 1987, pp. 125-137
5. Zeidner, N. S., Belasco, D. L., Dreitz, M. J., Frank, G. R. and Usinger, W. R. Gliding bacterial adjuvant stimulates feline cytokines in vitro and antigen-specific IgG in vivo. Vaccine 1995, 13, 1294-1301.
6. Shiigi, S. M., Capwell, R. R., Grabstein, K. H. and Mishell, R. I. Sera and the induction of immune responses. III. Adjuvant obtained from gliding bacteria with properties distinct from enteric bacterial lipopolysaccharide. Journal of Immunology 1977, 119, 679-688.
7. Allison, A. C. and Byars, N. E. Syntex adjuvant formulation. Research on Immunology 1992, 143, 519-525.
8. Kensil, C. R., Barrett, C., Kushner, N., Neltz, G., Storey, J., Patel, U., Recchia, J., Aubert, A. and Marciani, D. Development of a genetically engineered vaccine against feline leukemia virus infection. Journal of the American Veterinary Medical Association 1991, 199, 1423-1427.
9. Alving, C. R., Detrick, B., Richards, R. L., Lewis, M. G., Shafferman, A. and Eddy, G. A. Novel adjuvant strategies for experimental malaria and AIDS vaccines. Annals of the New York Academy of Sciences 1993, 690, 265-275.